肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

上尿路尿路上皮癌诊断与治疗中国专家共识

2018-07-20 中国医师协会泌尿外科医师分会 中华泌尿外科杂志.2018.39(7):485-488.

上尿路尿路上皮癌

由于整体而言上尿路尿路上皮癌(UTUC)发病率相对较低，在疾病诊断和治疗策略中还有一些存在争议之处。为提高泌尿外科医生对该病的诊疗水平，规范临床操作，中国医师协会泌尿外科医师分会肿瘤专业委员会、中国医师协会泌尿外科医师分会上尿路尿路上皮癌(CUDA—UTUC)协作组组织相关专家，结合国外相关指南、国内外近年的报道和我国临床诊疗现状，编制此共识。

中文标题：

上尿路尿路上皮癌诊断与治疗中国专家共识

发布机构：

中国医师协会泌尿外科医师分会

发布日期：

2018-07-20

简要介绍：

由于整体而言上尿路尿路上皮癌(UTUC)发病率相对较低，在疾病诊断和治疗策略中还有一些存在争议之处。为提高泌尿外科医生对该病的诊疗水平，规范临床操作，中国医师协会泌尿外科医师分会肿瘤专业委员会、中国医师协会泌尿外科医师分会上尿路尿路上皮癌(CUDA—UTUC)协作组组织相关专家，结合国外相关指南、国内外近年的报道和我国临床诊疗现状，编制此共识。 

拓展指南：与尿路相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=上尿路尿路上皮癌诊断与治疗中国专家共识)] GetToolGuiderByIdResponse(projectId=1, id=bcd841c001e7321a, title=上尿路尿路上皮癌诊断与治疗中国专家共识, enTitle=, guiderFrom=中华泌尿外科杂志.2018.39(7):485-488., authorId=null, author=, summary=由于整体而言上尿路尿路上皮癌(UTUC)发病率相对较低，在疾病诊断和治疗策略中还有一些存在争议之处。为提高泌尿外科医生对该病的诊疗水平，规范临床操作，中国医师协会泌尿外科医师分会肿瘤专业委员会、中国医师协会泌尿外科医师分会上尿路尿路上皮癌(CUDA—UTUC)协作组组织相关专家，结合国外相关指南、国内外近年的报道和我国临床诊疗现状，编制此共识。 , cover=, journalId=null, articlesId=null, associationId=1810, associationName=中国医师协会泌尿外科医师分会, associationIntro=, copyright=0, guiderPublishedTime=Fri Jul 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>由于整体而言上尿路尿路上皮癌(UTUC)发病率相对较低，在疾病诊断和治疗策略中还有一些存在争议之处。为提高泌尿外科医生对该病的诊疗水平，规范临床操作，中国医师协会泌尿外科医师分会肿瘤专业委员会、中国医师协会泌尿外科医师分会上尿路尿路上皮癌(CUDA—UTUC)协作组组织相关专家，结合国外相关指南、国内外近年的报道和我国临床诊疗现状，编制此共识。 </div> <div><br> </div> 拓展指南：<strong>与<font color="red">尿路</font>相关指南：</strong><br><ul><li><a title="2019 CUA指南：神经源性下尿路功能障碍的诊断，管理和监测-概要" target="_blank" href="https://www.medsci.cn/guideline/show_article.do?id=267191c001e51a71">2019 CUA指南：神经源性下尿路功能障碍的诊断，管理和监测-概要</a></li> <li><a title="2019 SIR多学科立场声明：前列腺动脉栓塞治疗良性前列腺增生引起的下尿路症状" target="_blank" href="https://www.medsci.cn/guideline/show_article.do?id=6e9861c001e26261">2019 SIR多学科立场声明：前列腺动脉栓塞治疗良性前列腺增生引起的下尿路症状</a></li> <li><a title="2019 CUA指南：神经源性下尿路功能障碍的诊断，管理和监测" target="_blank" href="https://www.medsci.cn/guideline/show_article.do?id=c46b41c001e0607a">2019 CUA指南：神经源性下尿路功能障碍的诊断，管理和监测</a></li> <li><a title="上尿路尿路上皮癌外科治疗中国专家共识" target="_blank" href="https://www.medsci.cn/guideline/show_article.do?id=523021c0016e7599">上尿路尿路上皮癌外科治疗中国专家共识</a></li> <li><a title="2018 CUA指南：男性下尿路症状/良性前列腺增生(更新版)" target="_blank" href="https://www.medsci.cn/guideline/show_article.do?id=097ae1c00165a93c">2018 CUA指南：男性下尿路症状/良性前列腺增生(更新版)</a></li> 更多信息请点击：<a target="_blank" href="https://www.medsci.cn/guideline/list.do?q=%E5%B0%BF%E8%B7%AF">有关尿路更多指南</a></ul>, tagList=[TagDto(tagId=84577, tagName=上尿路尿路上皮癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=15128, appHits=377, showAppHits=6, pcHits=12388, showPcHits=3875, likes=78, shares=23, comments=9, approvalStatus=1, publishedTime=Tue Jul 30 22:38:48 CST 2019, publishedTimeString=2018-07-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Jul 30 22:38:48 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 05:41:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=上尿路尿路上皮癌诊断与治疗中国专家共识)])
上尿路尿路上皮癌诊断与治疗中国专家共识
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1219573, encodeId=cfdb12195e368, content=有没有最新的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=395f2314684, createdName=jiaqilei, createdTime=Sat May 14 14:13:20 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964858, encodeId=26599648582a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200803/d669a8255ef042b4b50cb4b323fac1e4/3da0f519fc71432ca9a2f4c05279c082.jpg, createdBy=a8312408082, createdName=chenny, createdTime=Wed May 12 11:30:01 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915618, encodeId=21d9915618e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210111/616dbbab55eb4932bdf19a58a012e1c4/b9af285344e4473e9f6f9c6ac8935960.jpg, createdBy=844f2121780, createdName=1581fad5efm, createdTime=Mon Jan 11 18:56:50 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905062, encodeId=3c4490506254, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46c3285395, createdName=12d843f0m29暂无昵称, createdTime=Sat Dec 05 01:20:15 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898326, encodeId=9d6589832602, content=赚积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlsERBcznAdmbubHPOibYH38pqw4YpCd4tefxiclGCPVJQFvCg1VkIicDKjsiaJk1Z5ibcJyjgdIPc5lQ/132, createdBy=edf84781010, createdName=834882315, createdTime=Tue Nov 10 20:34:05 CST 2020, time=2020-11-10, status=1, ipAttribution=)]
    2022-05-14 jiaqilei

    有没有最新的

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1219573, encodeId=cfdb12195e368, content=有没有最新的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=395f2314684, createdName=jiaqilei, createdTime=Sat May 14 14:13:20 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964858, encodeId=26599648582a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200803/d669a8255ef042b4b50cb4b323fac1e4/3da0f519fc71432ca9a2f4c05279c082.jpg, createdBy=a8312408082, createdName=chenny, createdTime=Wed May 12 11:30:01 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915618, encodeId=21d9915618e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210111/616dbbab55eb4932bdf19a58a012e1c4/b9af285344e4473e9f6f9c6ac8935960.jpg, createdBy=844f2121780, createdName=1581fad5efm, createdTime=Mon Jan 11 18:56:50 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905062, encodeId=3c4490506254, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46c3285395, createdName=12d843f0m29暂无昵称, createdTime=Sat Dec 05 01:20:15 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898326, encodeId=9d6589832602, content=赚积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlsERBcznAdmbubHPOibYH38pqw4YpCd4tefxiclGCPVJQFvCg1VkIicDKjsiaJk1Z5ibcJyjgdIPc5lQ/132, createdBy=edf84781010, createdName=834882315, createdTime=Tue Nov 10 20:34:05 CST 2020, time=2020-11-10, status=1, ipAttribution=)]
    2021-05-12 chenny

    受益匪浅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1219573, encodeId=cfdb12195e368, content=有没有最新的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=395f2314684, createdName=jiaqilei, createdTime=Sat May 14 14:13:20 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964858, encodeId=26599648582a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200803/d669a8255ef042b4b50cb4b323fac1e4/3da0f519fc71432ca9a2f4c05279c082.jpg, createdBy=a8312408082, createdName=chenny, createdTime=Wed May 12 11:30:01 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915618, encodeId=21d9915618e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210111/616dbbab55eb4932bdf19a58a012e1c4/b9af285344e4473e9f6f9c6ac8935960.jpg, createdBy=844f2121780, createdName=1581fad5efm, createdTime=Mon Jan 11 18:56:50 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905062, encodeId=3c4490506254, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46c3285395, createdName=12d843f0m29暂无昵称, createdTime=Sat Dec 05 01:20:15 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898326, encodeId=9d6589832602, content=赚积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlsERBcznAdmbubHPOibYH38pqw4YpCd4tefxiclGCPVJQFvCg1VkIicDKjsiaJk1Z5ibcJyjgdIPc5lQ/132, createdBy=edf84781010, createdName=834882315, createdTime=Tue Nov 10 20:34:05 CST 2020, time=2020-11-10, status=1, ipAttribution=)]
    2021-01-11 1581fad5efm

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1219573, encodeId=cfdb12195e368, content=有没有最新的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=395f2314684, createdName=jiaqilei, createdTime=Sat May 14 14:13:20 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964858, encodeId=26599648582a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200803/d669a8255ef042b4b50cb4b323fac1e4/3da0f519fc71432ca9a2f4c05279c082.jpg, createdBy=a8312408082, createdName=chenny, createdTime=Wed May 12 11:30:01 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915618, encodeId=21d9915618e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210111/616dbbab55eb4932bdf19a58a012e1c4/b9af285344e4473e9f6f9c6ac8935960.jpg, createdBy=844f2121780, createdName=1581fad5efm, createdTime=Mon Jan 11 18:56:50 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905062, encodeId=3c4490506254, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46c3285395, createdName=12d843f0m29暂无昵称, createdTime=Sat Dec 05 01:20:15 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898326, encodeId=9d6589832602, content=赚积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlsERBcznAdmbubHPOibYH38pqw4YpCd4tefxiclGCPVJQFvCg1VkIicDKjsiaJk1Z5ibcJyjgdIPc5lQ/132, createdBy=edf84781010, createdName=834882315, createdTime=Tue Nov 10 20:34:05 CST 2020, time=2020-11-10, status=1, ipAttribution=)]
    2020-12-05 12d843f0m29暂无昵称

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1219573, encodeId=cfdb12195e368, content=有没有最新的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=395f2314684, createdName=jiaqilei, createdTime=Sat May 14 14:13:20 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964858, encodeId=26599648582a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200803/d669a8255ef042b4b50cb4b323fac1e4/3da0f519fc71432ca9a2f4c05279c082.jpg, createdBy=a8312408082, createdName=chenny, createdTime=Wed May 12 11:30:01 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915618, encodeId=21d9915618e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210111/616dbbab55eb4932bdf19a58a012e1c4/b9af285344e4473e9f6f9c6ac8935960.jpg, createdBy=844f2121780, createdName=1581fad5efm, createdTime=Mon Jan 11 18:56:50 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905062, encodeId=3c4490506254, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d46c3285395, createdName=12d843f0m29暂无昵称, createdTime=Sat Dec 05 01:20:15 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898326, encodeId=9d6589832602, content=赚积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlsERBcznAdmbubHPOibYH38pqw4YpCd4tefxiclGCPVJQFvCg1VkIicDKjsiaJk1Z5ibcJyjgdIPc5lQ/132, createdBy=edf84781010, createdName=834882315, createdTime=Tue Nov 10 20:34:05 CST 2020, time=2020-11-10, status=1, ipAttribution=)]
    2020-11-10 834882315

    赚积分

    0

相关指南

上尿路尿路上皮癌外科治疗中国专家共识

中国抗癌协会泌尿肿瘤专业委员会 · 2018-11-30